Rob Brown
President and CEO, Adentra
Replay available
ADENTRA Inc. (TSX: ADEN) Q3 2025 earnings conference call, held 2025-11-10. Replay captured from the company's public earnings webcast.

President and CEO, Adentra
Vice President and CFO, Adentra
Analyst, Cormark
Analyst, CIBC
Analyst, Desjardins
Analyst, National Bank
Analyst, Scotiabank
Good morning, my name is Joanna and I will be your conference operator today. I would like to welcome everyone to the ADEMTRA third quarter 2025 results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. To ask a question during this time, simply press star then the number one on your telephone keypad. To withdraw your question, please press star then the number two. With me on the call are Rob Brown, Adentra's President and CEO, and Fez Kamali, Vice President and CFO. Adentra's third quarter 2025 earnings release, financial statements, MTNA, and other quarterly filings are available on the investor section of our website at www.adentragroup.com. These statements have also been filed on Adentra's profile on CDAR Plus at www.cdarplus.ca. I want to remind listeners that management's comments during this call may include forward-looking statements. These statements involve various known and unknown risks and uncertainties and are based on management's current expectations and beliefs, which may prove to be incorrect. Actual results could differ materially from those described in these forward-looking statements. Please refer to the text in Edentra's earnings press release and financial filings for a discussion of the risks and uncertainties associated with these forward-looking statements. All dollar figures referred to today are in U.S. dollars unless stated otherwise. I would now like to turn the call over to Rob Brown. Please go ahead. Thanks, and good morning, everyone. We delivered strong results in the third quarter, highlighting the resilience and consistency of the Dentures operating model. We grew sales, adjusted EBITDA, and maintained strong earnings des...